BACKGROUND AND PURPOSE: We sought to find predictors for hemorrhagic complications in patients with acute ischemic stroke treated with multimodal endovascular therapy. MATERIALS AND METHODS: We retrospectively reviewed patients with acute ischemic stroke treated with multimodal endovascular therapy from May 1999 to March 2006. We reviewed clinical and angiographic data, admission CT Alberta Stroke Programme Early CT Score (ASPECTS), and the therapeutic endovascular interventions used. Posttreatment CT scans were reviewed for the presence of a parenchymal hematoma or hemorrhagic infarction based on defined criteria. Predictors for these types of hemorrhages were determined by logistic regression analysis. RESULTS: We identified 185 patients with a mean age of 65+/-13 years and mean National Institutes of Health Stroke Scale score of 17+/-4. Sixty-nine patients (37%) developed postprocedural hemorrhages: 24 (13%) parenchymal hematomas and 45 (24%) hemorrhagic infarctions. Patients with tandem occlusions (odds ratio [OR] 4.6 [1.4-6.5], P<.016), hyperglycemia (OR 2.8 [1.1-7.7], P<.043), or treated concomitantly with intravenous (IV) tissue plasminogen activator (tPA) and intra-arterial (IA) urokinase (OR 5.1 [1.1-25.0], P<.041) were at a significant risk for a parenchymal hematoma. Hemorrhagic infarction occurred significantly more in patients presenting with an ASPECTS<or=7 (OR 1.9 [1.3-2.7], P<.01). CONCLUSIONS: Hemorrhagic infarctions are related to the extent of infarct based on presentation CT, whereas parenchymal hematomas are associated with the presence of tandem occlusions, hyperglycemia, and treatment with both IV tPA and IA urokinase in patients with acute stroke treated with multimodal endovascular therapy.
BACKGROUND AND PURPOSE: We sought to find predictors for hemorrhagic complications in patients with acute ischemic stroke treated with multimodal endovascular therapy. MATERIALS AND METHODS: We retrospectively reviewed patients with acute ischemic stroke treated with multimodal endovascular therapy from May 1999 to March 2006. We reviewed clinical and angiographic data, admission CT Alberta Stroke Programme Early CT Score (ASPECTS), and the therapeutic endovascular interventions used. Posttreatment CT scans were reviewed for the presence of a parenchymal hematoma or hemorrhagic infarction based on defined criteria. Predictors for these types of hemorrhages were determined by logistic regression analysis. RESULTS: We identified 185 patients with a mean age of 65+/-13 years and mean National Institutes of Health Stroke Scale score of 17+/-4. Sixty-nine patients (37%) developed postprocedural hemorrhages: 24 (13%) parenchymal hematomas and 45 (24%) hemorrhagic infarctions. Patients with tandem occlusions (odds ratio [OR] 4.6 [1.4-6.5], P<.016), hyperglycemia (OR 2.8 [1.1-7.7], P<.043), or treated concomitantly with intravenous (IV) tissue plasminogen activator (tPA) and intra-arterial (IA) urokinase (OR 5.1 [1.1-25.0], P<.041) were at a significant risk for a parenchymal hematoma. Hemorrhagic infarction occurred significantly more in patients presenting with an ASPECTS<or=7 (OR 1.9 [1.3-2.7], P<.01). CONCLUSIONS:Hemorrhagic infarctions are related to the extent of infarct based on presentation CT, whereas parenchymal hematomas are associated with the presence of tandem occlusions, hyperglycemia, and treatment with both IV tPA and IA urokinase in patients with acute stroke treated with multimodal endovascular therapy.
Authors: Rishi Gupta; Howard Yonas; James Gebel; Steven Goldstein; Michael Horowitz; Stephen Z Grahovac; Lawrence R Wechsler; Maxim D Hammer; Ken Uchino; Tudor G Jovin Journal: Stroke Date: 2006-09-07 Impact factor: 7.914
Authors: Imanuel Dzialowski; Michael D Hill; Shelagh B Coutts; Andrew M Demchuk; David M Kent; Olaf Wunderlich; Rüdiger von Kummer Journal: Stroke Date: 2006-02-23 Impact factor: 7.914
Authors: Rishi Gupta; Nirav A Vora; Michael B Horowitz; Ashis H Tayal; Maxim D Hammer; Ken Uchino; Elad I Levy; Lawrence R Wechsler; Tudor G Jovin Journal: Stroke Date: 2006-03-09 Impact factor: 7.914
Authors: Enming J Su; Linda Fredriksson; Melissa Geyer; Erika Folestad; Jacqueline Cale; Johanna Andrae; Yamei Gao; Kristian Pietras; Kris Mann; Manuel Yepes; Dudley K Strickland; Christer Betsholtz; Ulf Eriksson; Daniel A Lawrence Journal: Nat Med Date: 2008-06-22 Impact factor: 53.440
Authors: Raul G Nogueira; Rishi Gupta; Tudor G Jovin; Elad I Levy; David S Liebeskind; Osama O Zaidat; Ansaar Rai; Joshua A Hirsch; Daniel P Hsu; Marilyn M Rymer; Ashis H Tayal; Ridwan Lin; Sabareesh K Natarajan; Ashish Nanda; Melissa Tian; Qing Hao; Junaid S Kalia; Michael Chen; Alex Abou-Chebl; Thanh N Nguyen; Albert J Yoo Journal: J Neurointerv Surg Date: 2014-01-08 Impact factor: 5.836
Authors: Zhong-Song Shi; David S Liebeskind; Yince Loh; Jeffrey L Saver; Sidney Starkman; Paul M Vespa; Nestor R Gonzalez; Satoshi Tateshima; Reza Jahan; Lei Feng; Chad Miller; Latisha K Ali; Bruce Ovbiagele; Doojin Kim; Gary R Duckwiler; Fernando Viñuela Journal: Stroke Date: 2010-11-04 Impact factor: 7.914
Authors: V Misra; R El Khoury; R Arora; P R Chen; S Suzuki; N Harun; N R Gonzales; A D Barreto; J C Grotta; S I Savitz Journal: AJNR Am J Neuroradiol Date: 2011-02-24 Impact factor: 3.825
Authors: Alex Abou-Chebl; Sharon D Yeatts; Bernard Yan; Kevin Cockroft; Mayank Goyal; Tudor Jovin; Pooja Khatri; Phillip Meyers; Judith Spilker; Rebecca Sugg; Katja E Wartenberg; Tom Tomsick; Joe Broderick; Michael D Hill Journal: Stroke Date: 2015-07-02 Impact factor: 7.914
Authors: Yeon Hong Yoon; Woong Yoon; Min Young Jung; Nam Yeol Yim; Byeong Chae Kim; Heoung Keun Kang Journal: Neuroradiology Date: 2013-05-24 Impact factor: 2.804